CAIT urges SEBI to stop PharmEasy's IPO
New Delhi
10-December-2021

photo:IANS
The Confederation of All India Traders on Friday wrote to the Securities and Exchange Board of India urging the marking regulator not to allow e-pharmacy firm PharmEasy's initial public offering.
Citing a Delhi High Court order passed in 2018, the traders' body said that sale of medicines over the internet is not allowed.
API Holdings, the parent company of the e-pharmacy firm PharmEasy has reportedly filed the 'Draft Red Herring Prospectus' to the market regulator recently.
"We believe that investor wealth worth billions is at stake if this IPO is approved by SEBI. We are sure that it will receive your kind and immediate attention," the statement added.
In addition, the traders' body alleged that the Pharmeasy has mentioned Thyrocare as its subsidiary in the DRHP submitted to the SEBI, without any order from the Competition Commission of India, whcih prevents activities that potentially may have an adverse effect on business.
The South Chemists and Distributors Association had also submitted a letter to the SEBI with requests on the same line. -IANS
Watch This TWL Video
More Headlines
AI Cybersecurity Startup Neural Defend Raises $600K in Pre-Seed Round
Chennai Doctor and Family Found Dead Amid ₹5 Crore Business Loss
Karnataka Withdraws CID Probe in Ranya Rao Gold Smuggling Case
New Kerala Guv Strikes Cordial Tone, Hosts CM Vijayan And FM Sitharaman In Delhi
Digital Payments Surge in India: 18,120 Crore Transactions in FY24-25
AI Cybersecurity Startup Neural Defend Raises $600K in Pre-Seed Round
Chennai Doctor and Family Found Dead Amid ₹5 Crore Business Loss
Karnataka Withdraws CID Probe in Ranya Rao Gold Smuggling Case
New Kerala Guv Strikes Cordial Tone, Hosts CM Vijayan And FM Sitharaman In Delhi
Digital Payments Surge in India: 18,120 Crore Transactions in FY24-25